Online ISSN 2313-1519
Print    ISSN 1812-2892
Abstract - The Importance of Vitamin-D in Androgenic Alopecia and Telogen Effluvium
[PDF]            [Full text/HTML]           
Gülbahar Saraç, Tuba Tülay Koca

ABSTRACT

Aim: Androgenic alopecia (AA) is defined as progressive miniaturization of scarless hair follicle prevailing among both male and female. Telogen effluvium (TE) is the most common hair loss form accompanying systemic diseases. It is aimed to determine the role of vitamine D, the significance of which has been increasing in recent years, in hair loss problem within the scope of this study. 

Methods: The patients who applied to Dermatology clinic with the complaint of hair loss and diagnosed androgenic alopecia and telogen effluvium by clinic examination between the years 2015-2016 were included into this study. The age, gender and 25’OHvitamin-D level of the patients were recorded retrospectively.

Results: One-hundred eighty seven (N=187) participants (140 female / 47 male) were included in this study. Fifty-eight (N=58) patients (28 female / 30 male) with androgenic alopecia diagnosis formed the first group; 71 patients (65 female / 6 male) with telogen effluvium were formed the second group and 58 healthy volunteers (47 female / 11male) were included in the control group. When Vitamin-D level of first group (AA) was compared with that of the second group (TE) and the control group, there was a statistically significant difference observed (p=0.01/p=0.01 respectively). However, there was no statistically significant difference between the vitamin-D level of second group (TE) and that of the healthy control group (p=0.61).

Conclusion: The level of 25'(OH) vit D was found high in androgenic alopecia group than telogen effluvium and controls. Revealing the relationship between vitamin-D level and hair loss might give us the opportunity to come up with new treatment options considering refractory patients.

Keywords: vitamin D, telogen effluvium, androgenic alopecia

Corresponding Author: Tuba Tülay KOCA, Assistant Professor, Department of Physical MedicIne and Rehabilitation, Sütçü İmam University, Kahramanmaraş, Turkey. Phone: +90 5063819295. E-mail: tuba_baglan@yahoo.com

 

REFERENCES

1. Herskovitz I, Tosti A. Female Pattern Hair Loss. Int J Endocrinol Metab. 2013; 11:9860.
https://doi.org/10.5812/ijem.9860

2. Dawber RPR, Ebling FJG, Wojnarowska FT. Disorders of hair. Textbook of dermatology. Ed. Champion RH, Burton JL, Ebling FJG. 5. Eddition. Oxford, Blackwell ScientificPubl, 1992; 2533-638.

3. Lolli F, Pallotti F, Rossi A, Fortuna MC, Caro G, Lenzi A, Sansone A, Lombardo F. Androgenetic alopecia: a review. Endocrine. 2017; 57(1):9-17.
https://doi.org/10.1007/s12020-017-1280-y

4. Hillmer AM, Hanneken S, Ritzmann S, Becker T, Freudenberg J, Brockschmidt FF, et al. Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. Am J Hum Genet. 2005; 77(1):140-8.
https://doi.org/10.1086/431425

5. Kelly Y, Blanco A, Tosti A. Androgenetic Alopecia: An Update of Treatment Options. Drugs. 2016; 76(14):1349-64.
https://doi.org/10.1007/s40265-016-0629-5

6. Saitoh M, Uzuka M, Sakamoto M. Human haircycle. J Invest Dermatol. 1970; 54:65-81.
https://doi.org/10.1111/1523-1747.ep12551679

7. Malkud S. Telogen Effluvium: A Review. J Clin Diagn Res. 2015; 9(9):WE01-3.
https://doi.org/10.7860/JCDR/2015/15219.6492

8. Grover C, Khurana A. Telogen effluvium. Indian J Dermatol Venereol Leprol. 2013; 79(5):591-603.
https://doi.org/10.4103/0378-6323.116731

9. Rebora A. Intermittent Chronic Telogen Effluvium. Skin Appendage Disord. 2017; 3(1):36-38. https://doi.org/10.1159/000455882

10. Gerkowicz A, Chyl-Surdacka K, Krasowska D, Chodorowska G. The Role of Vitamin D in Non-Scarring Alopecia. Int J Mol Sci. 2017; 18(12):E2653.
https://doi.org/10.3390/ijms18122653

11. Cash TF: The psychosocial consequences of androgenic alopecia: a review of the research literature. Br J Dermatol. 1999; 141:398-405.
https://doi.org/10.1046/j.1365-2133.1999.03030.x

12. Kutlubay Z, Bağlam S, Engin B, Serdaroğlu S. Erkeklerde androgenetik alopesi. Türkderm. 2014; 48:36-9.

13. Hamilton JB: Male hormone stimulation is prerequisite and an incitant in common baldness. Am J Anat. 1942; 71:451-80.
https://doi.org/10.1002/aja.1000710306

14. Headington JT. Telogen effluvium. New concepts and review. Arch Dermatol. 1993; 129(3):356-363.
https://doi.org/10.1001/archderm.1993.01680240096017

15. Whiting DA. Chronic telogen effluvium: increased scalp hair shedding in middle-aged female. J Am Acad Dermatol. 1996; 35(6):899- 906.
https://doi.org/10.1016/S0190-9622(96)90113-9

16. Myszka M, Klinger M. The immuno modulatory role of Vitamin D. Postepy Hig Med Dosw (Online). 2014;68:865-78
https://doi.org/10.5604/17322693.1110168

17. Morimoto S, Kumahara Y. A patient with psoriasis cured by 1 alpha-hydroxy VitD3. Med J Osaka Univ 1985;35:51-4

18. Parsad D, Saini R, Nagpal R. Calcipotriol in vitiligo: a preliminary study. Pediatr Dermatol. 1999; 16:317-20.
https://doi.org/10.1046/j.1525-1470.1999.00083.x

19. Cunningham BB, Landells ID, Langman C, Sailer DE, Paller AS. Topical calcipotriene for morphea/linearscleroderma. J Am Acad Dermatol. 1998; 39:211-36.
https://doi.org/10.1016/S0190-9622(98)70077-5

20. Wegienka G, Havstad S, Zoratti EM, Kim H, Ownby DR, Johnson C C. Association between vitamin D levels and allergy-related outcomes vary by race and other factors. J Allergy Clin Immunol. 2015;136(5):1309-14.
https://doi.org/10.1016/j.jaci.2015.04.017

21. Mirzakhani H, Al-Garawi A, Weiss ST, Litonjua AA. Vitamin D and the development of allergic disease: how important is it? Clin Exp Allergy. 2015; 45(1):114-25.
https://doi.org/10.1111/cea.12430

22. Sakai Y, Kishimoto J, Demay MB: Metabolic and cellular analysis of alopecia in vitamin D receptor knock out mice. J ClinInvest. 2001; 107:961- 6.

https://doi.org/10.1172/JCI11676

23. Mady LJ, Ajibade DV, Hsaio C, Teichert A, Fong C, Wang Y, et al. The Transient Role for Calcium and Vitamin D during the Developmaletal Hair Follicle Cycle. J Invest Dermatol. 2016; 16: S0022-202X(16)30876-4.
https://doi.org/10.1016/j.jid.2016.02.813

24. Xie Z, Komuves L, Yu QC, Elalieh H, Ng DC, Leary C, et al. Lack of the vitamin D receptor is associated with reduced epidermal differentiation and hair follicle growth. J Invest Dermatol. 2002;118(1):11-6.
https://doi.org/10.1046/j.1523-1747.2002.01644.x

25. Beer S, Tieder M, Kohelet D, et al: Vitamin D resistant rickets with alopecia: A form of end organ resistanceto 1,25 dihydroxy vitamin D. Clin Endocrinol. 1981; 14:395-402.
https://doi.org/10.1111/j.1365-2265.1981.tb00626.x

26. Mahamid M, Abu-Elhija O, Samamra M, Mahamid A, Nseir W. Association between vitamin D levels and alopecia areata. Isr Med Assoc J. 2014; 16(6):367-70.

27. Fawzi MM, Mahmoud SB, Ahmed SF, Shaker OG. Assessmalet of vitamin D receptors in alopecia areata and androgenic alopecia. J Cosmet Dermatol. 2016;
https://doi.org/10.1111/jocd.12224

28. H. Rasheed a D. Mahgoub a R. Hegazy a M. El-Komy a R. Abdel Hay a M.A. Hamid a E. et al. Serum Ferritinand Vitamin D in Female Hair Loss: Do They Play a Role? Skin Pharmacol Physiol. 2013; 26:101–107.
https://doi.org/10.1159/000346698

 

Volume 4, Number 50 (2018)